Free Trial

Elevai Labs Q4 2023 Earnings Report

Elevai Labs logo
$2.48 +0.19 (+8.30%)
(As of 05:42 PM ET)

Elevai Labs EPS Results

Actual EPS
-$16.00
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Elevai Labs Revenue Results

Actual Revenue
$0.70 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Elevai Labs Announcement Details

Quarter
Q4 2023
Time
N/A

Conference Call Resources

I was wrong. Dead wrong. (Ad)

Something is stirring deep in Silicon Valley. My team and I have been watching the tech markets closely. And something BIG is about to happen.

“The Final Frontier” of tech is here, click now to watch this exclusive video
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Elevai Labs? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Elevai Labs and other key companies, straight to your email.

About Elevai Labs

Elevai Labs (NASDAQ:ELAB), a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California.

View Elevai Labs Profile

More Earnings Resources from MarketBeat